Clinical Trials Logo

Clinical Trial Summary

The investigators are planning to determine the effect of the timing of oxytocin administration on the amount of blood loss, necessity for additional medical or surgical interventions.


Clinical Trial Description

The investigators are studying the effects of the timing of intramuscular oxytocin administration in the third stage of labour. The investigators are measuring the postpartum blood loss: quantitatively in the postpartum 1st hour and indirectly by the decrease in the hemoglobin-haematocrit levels in the postpartum 24th hour. The investigators are monitoring the length of the third stage of labour, and the need for extra uterotonics and/or surgical interventions. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02495272
Study type Interventional
Source Bagcilar Training and Research Hospital
Contact Dogukan Yildirim, MD
Phone +905063284383
Email dogukanyildirim@yahoo.com
Status Recruiting
Phase N/A
Start date June 2014
Completion date January 2016

See also
  Status Clinical Trial Phase
Recruiting NCT01373801 - Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations N/A
Completed NCT01954186 - When and How to Administer Oxytocin for Active Management of Third Stage of Labour N/A